Rosoff, J D <br/><br/>
A second-generation blood substitute (perfluorodichlorooctane emulsion) does not activate complement during an ex vivo circulation model of bypass.  [electronic resource] 

 -  Journal of cardiothoracic and vascular anesthesia  Aug 1998 
 - 397-401 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1053-0770 
<br/><br/><label>Standard No.: </label>10.1016/s1053-0770(98)90191-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Anticoagulants--therapeutic use<br/>Blood Substitutes--administration & dosage<br/>Cardiopulmonary Bypass--instrumentation<br/>Complement Activation--drug effects<br/>Complement C3a--analysis<br/>Complement Factor B--analysis<br/>Crystalloid Solutions<br/>Emulsions<br/>Female<br/>Filtration--instrumentation<br/>Fluorocarbons--administration & dosage<br/>Heparin--therapeutic use<br/>Humans<br/>Hydrocarbons, Chlorinated--administration & dosage<br/>Hydrocarbons, Fluorinated--administration & dosage<br/>Isotonic Solutions<br/>Male<br/>Middle Aged<br/>Oxygenators, Membrane<br/>Plasma Substitutes--therapeutic use<br/>Prospective Studies<br/>Single-Blind Method